Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EBOS Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: EBOS Group’s earnings surge – or plunge – but bottom line is, pharmacies are in rude health
Health & Biotech
Scott Power: Chemist Warehouse and Sigma officially say ‘I do’ as CSL & Cochlear feels heartache
Health & Biotech
Scott Power: ACCC’s approval of Sigma, Chemist Warehouse union turned heads this week
Health & Biotech
Health Check: Neuren’s ‘Willy Wonka’ voucher shows how a piece of paper can be worth US$50m
Health & Biotech
Scott Power: Which ASX health stocks reaffirm FY25 guidance?
Health & Biotech
Health Check: Despite headwinds, Australia’s third force in pharmacy finds prescription for growth
Health & Biotech
Scott Power: Which health ‘underperformer’ just made a big move?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
News
ScoPo’s Powerplays: ASX health stocks rise as ‘Pro Medicus again hit the ball out of the park’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks hit resistance in first week of FY25
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as Sonic cuts FY24 profit guidance
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
News
Closing Bell: Markets up almost 0.1pc on Friday as the cows take control
News
Morgan Stanley name drops ASX-listed Ebos as likely to fatten-up on Asia’s Ozempic weight-loss craze
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as Morgans upgrades Sigma on proposed Chemist Warehouse merger
Health & Biotech
ScoPo’s Powerplays: ASX healthcare rises in Christmas rally as EBOS ups stake in Transmedic
Health & Biotech
